Pankaj Jain of Sunteck Wealthmax recommends buying GMR Infrastructure with a target of Rs 24.95 and Peninsula Land with a target of Rs 43.45.
Krish Subramanium of Asit C Mehta advises buying Mangalore Refinery and Petrochemicals for a target price of Rs 45.75 and Torrent Pharma for a target price of Rs 512.
Dharmesh Kant of India Nivesh Securities advises buying Bajaj Finance with a target price of Rs 1,320 and JB Chemicals with a target price of Rs 99.
Alembic Pharmaceuticals has reported a sales turnover of Rs 484.28 crore and a net profit of Rs 61.64 crore for the quarter ended Sep '13
Saurabh Mittal of Swadeshi Credits recommends buying Motherson Sumi with a target price of Rs 237 and Canara Bank with a target price of Rs 232.
Firstcall Research is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 160 in its September 12, 2013 research report.
Prakash Diwan of Altamount Capital Management recommended buying Hindustan Zinc with a target price of Rs 129.90 and Alembic Pharma with a target price of Rs 145.50.
Alembic Pharmaceuticals has reported a sales turnover of Rs 426.37 crore and a net profit of Rs 46.64 crore for the quarter ended Jun '13
In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.
According to Satish Gupta of astrostocktips.in, paints stocks like Asian Paints, Berger Paints and technology stocks like Hexaware Technologies, Tata Consultancy Services will get astrological support.
According to Satish Gupta of astrostocktips.in, personal care stocks like Hindustan Unilever, Dabur India and pharma stocks like Lupin, Divis Laboratories, Cipla will get astrological support.
Technologystocks like Wipro, HCL Technologies and leather stocks like Bata India, Sreeleathers will get astrological support, says Satish Gupta of astrostocktips.in.
According to Satish Gupta of astrostocktips.in, technology stocks like Wipro, HCL Technologies, Tata Consultancy Services and pharma stocks like Divis Laboratories, Sun Pharmaceutical Industries to get astrological support.
Global biopharma company, UCB filed separate cases against 15 drug makers including Ranbaxy, Aurobindo, Zydus, Sun Pharma, Glenmark, Alembic Pharmaceuticals.
Shahina Mukadam of Varun Capital recommends buying Chambal Fertilisers and Chemicals with a target of Rs 40 and advises to sell Hindustan Petroleum Corporation with a target of Rs 227.
Sharmila Joshi of Peerless Securities advised buying Alembic Pharma with a target price of Rs 168 and Escorts with a target price of Rs 80.
Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.
Ranbaxy shares declined a further 2 percent on Wednesday morning after a media report said a prominent hospital in Mumbai had advised doctors to stop using the pharma company's drugs.
Alembic Pharma is hopeful to increase operating margin by 100-120 basis points in current financial year on the back of strong growth in international and domestic generic business.
SP Tulsian, sptulsian.com advises traders to avoid Alembic Pharma at current levels.
Alembic Pharmaceuticals expects 100 basis points improvement in its EBITDA as it has earned exclusive rights to sell Pristiq generic tablets for 24 Months.
SP Tulsian of sptulsian.com advised buying Alembic Pharma at around Rs 82-84. He expects the stock to hit these levels in a week.
Nirmal Bang is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 119, in its March 05, 2013 research report.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Alembic Pharma has target of Rs 100, says SP Tulsian, sptulsian.com